EXACT Sciences Valuation
| EXAS Stock | USD 53.66 0.59 1.11% |
At this time, the firm appears to be undervalued. EXACT Sciences owns a latest Real Value of $65.06 per share. The recent price of the firm is $53.66. Our model computes the value of EXACT Sciences from analyzing the firm fundamentals such as Current Valuation of 11.49 B, return on asset of -0.0216, and Shares Outstanding of 185.08 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting EXACT Sciences' valuation include:
Price Book 3.038 | Enterprise Value 11.5 B | Enterprise Value Ebitda 322.9835 | Price Sales 3.6481 | Forward PE 2.5 K |
Undervalued
Today
Please note that EXACT Sciences' price fluctuation is very steady at this time. Calculation of the real value of EXACT Sciences is based on 3 months time horizon. Increasing EXACT Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the EXACT stock is determined by what a typical buyer is willing to pay for full or partial control of EXACT Sciences. Since EXACT Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of EXACT Stock. However, EXACT Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 53.66 | Real 65.06 | Target 106.38 | Hype 52.91 | Naive 54.61 |
The intrinsic value of EXACT Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence EXACT Sciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of EXACT Sciences helps investors to forecast how EXACT stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of EXACT Sciences more accurately as focusing exclusively on EXACT Sciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use EXACT Sciences' intrinsic value based on its ongoing forecasts of EXACT Sciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against EXACT Sciences' closest peers.
EXACT Sciences Cash |
|
EXACT Valuation Trend
EXACT Sciences' real value is important for investors to make better decisions and a more accurate overall view of EXACT Sciences' financial worth over time. Using both EXACT Sciences' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
EXACT Sciences Total Value Analysis
EXACT Sciences is currently forecasted to have valuation of 11.49 B with market capitalization of 9.82 B, debt of 2.55 B, and cash on hands of 728.04 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the EXACT Sciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.49 B | 9.82 B | 2.55 B | 728.04 M |
EXACT Sciences Investor Information
About 99.0% of the company shares are held by institutions such as insurance companies. The book value of EXACT Sciences was currently reported as 17.35. The company recorded a loss per share of 1.16. EXACT Sciences had not issued any dividends in recent years. Based on the key indicators related to EXACT Sciences' liquidity, profitability, solvency, and operating efficiency, EXACT Sciences is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.EXACT Sciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. EXACT Sciences has an asset utilization ratio of 38.63 percent. This implies that the Company is making $0.39 for each dollar of assets. An increasing asset utilization means that EXACT Sciences is more efficient with each dollar of assets it utilizes for everyday operations.EXACT Sciences Ownership Allocation
The majority of EXACT Sciences outstanding shares are owned by institutions. These other corporate entities are usually referred to as non-private investors looking to obtain positions in EXACT Sciences to benefit from reduced commissions. Thus, outside corporations are subject to a different set of regulations than regular investors in EXACT Sciences. Please pay attention to any change in the institutional holdings of EXACT Sciences as this could imply that something significant has changed or is about to change at the company. On June 8, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of EXACT Sciences's common stock.EXACT Sciences Profitability Analysis
The company reported the previous year's revenue of 2.5 B. Net Loss for the year was (204.15 M) with profit before overhead, payroll, taxes, and interest of 1.51 B.About EXACT Sciences Valuation
The stock valuation mechanism determines EXACT Sciences' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of EXACT Sciences based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of EXACT Sciences. We calculate exposure to EXACT Sciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of EXACT Sciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.8 B | 1.9 B | |
| Pretax Profit Margin | (0.08) | (0.08) | |
| Operating Profit Margin | (0.09) | (0.09) | |
| Net Loss | (0.08) | (0.09) | |
| Gross Profit Margin | 0.74 | 0.76 |
EXACT Sciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as EXACT Sciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 180.1 M | |
| Forward Price Earnings | 2500 |
EXACT Sciences Current Valuation Indicators
EXACT Sciences' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final EXACT Sciences' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as EXACT Sciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use EXACT Sciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes EXACT Sciences' worth.Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.